Related Experiment Video

Updated: Jan 25, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.4K

Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial

Yuji Otsuka1, Keita Idemoto2, Yutaka Hosoda3

  • 1Department of Psychiatry Asahi General Hospital Asahi City Japan.

Journal of General and Family Medicine
|May 9, 2019
PubMed

Insights

Clozapine can be safely retried in schizophrenia patients even after myocarditis. This approach may improve long-term outcomes and life expectancy for individuals with schizophrenia.

Area of Science:

  • Psychiatry
  • Cardiology

Background:

  • Schizophrenia is associated with reduced life expectancy.
  • Clozapine is a critical antipsychotic for managing mortality in schizophrenia.
  • Clozapine-induced myocarditis is a serious adverse event that can necessitate treatment discontinuation.

Observation:

  • A case study of a schizophrenia patient who developed myocarditis during initial clozapine treatment.
  • The patient's clozapine was discontinued due to myocarditis.
  • A subsequent successful retrial of clozapine was performed.

Findings:

  • The second clozapine trial involved a slower titration rate and avoided coadministration with sodium valproate.
  • The patient tolerated clozapine without recurrence of myocarditis for over 3.5 years.
  • This suggests that clozapine retrial is feasible after clozapine-induced myocarditis.

Implications:

  • Long-term clozapine therapy may be achievable for schizophrenia patients with a history of myocarditis.
  • Successful clozapine retrial could enhance treatment adherence and improve overall life expectancy in schizophrenia.
  • This case highlights a potential strategy to mitigate risks associated with clozapine while preserving its therapeutic benefits.

Keywords:
clozapinelife expectancymyocarditisretrialsodium valproate

More Related Videos

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

3.5K
The Successive Alleys Test of Anxiety in Mice and Rats05:05

The Successive Alleys Test of Anxiety in Mice and Rats

Published on: June 17, 2013

22.4K

Related Concept Videos

Ecological Succession02:17

Ecological Succession

Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.4K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
401
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
233
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
195
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
297
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.0K